Are Complacent Investors Setting the Market Up for a Fast and Furious Decline?
The market is down, but investors aren’t scared. Does that mean there’s more downside to come?
Moderna Leads the Charge as Pharma ETF Hits All-Time High
Tempus AI and Merck are key contributors to Moderna’s success.
2 Significant Positive Events Aren’t Enough to Fix the Market
A Treasury intervention and 170% move in Moderna produced only a 0.2% gain in the S&P 500.
Bonds Rallied. Stocks Rallied. Just Not In the Way We Like.
Defensive issues took the lead. Does that mean we could be in for more downside?
The Treasury Steps In, and I Ring the Register
I reduced three biotech winners, and not because I think they are going down.
Costco’s Healthcare Move Turns Heads. We’re Buying These Pharma Stocks Instead.
Is pharma heating up? Let’s chart four sector names and… Costco?
A Shift in Market Character, Not a Collapse
Sustained upside is less likely from here, as rotation is starting to turn defensive.
Bonds Finally Receive Some Attention
Bonds may have found a bid, but stocks haven’t, with new lows jumping on the NYSE and Nasdaq.
A Potential Tell as Chip Stocks Come Under Pressure
We continue to see a favorable fundamental outlook, but we’re waiting for a better technical one.
I Unpacked My Library and Rediscovered an Important Stock Market Lesson
In a digital age where everything lives in the cloud, I’m doubling down on physical books. Here’s why — and what 20 years of data revealed.